Actemra 80mg/4ml -AU (Tocilizumab Vials) 80mg/4ml

Actemra 80mg/4ml is an injectable medication containing tocilizumab, used to treat inflammatory conditions. This vial formulation provides 80mg of active ingredient in 4ml solution. It is designed for subcutaneous injection under medical supervision.

Strength

80mg/4ml

Manufacturer / TM Owner

Roche Pharma

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Tocilizumab, the active ingredient in Actemra 80mg/4ml, is commonly used to manage moderate to severe rheumatoid arthritis in adults. It may also be prescribed for other inflammatory conditions when conventional therapies are ineffective. Patients often ask, 'what is tocilizumab used for' in relation to autoimmune disorders.

Side Effects

Actemra 80mg/4ml works by targeting specific pathways in the immune system to reduce inflammation. Users may notice gradual improvement in joint pain and swelling over time. The medication is not a painkiller but helps address the underlying inflammatory process.

Precautions & Warnings

Store Actemra 80mg/4ml vials in a refrigerator between 2°C and 8°C, protecting them from light. Do not freeze or shake the vial. Always check the solution for particles or discoloration before use. Keep out of reach of children and pets.

Avoid Interactions

Actemra may interact with other immunosuppressants or medications that affect the immune system. Caution is advised when combining with live vaccines or strong CYP450 enzyme inhibitors. Always inform your healthcare provider about all medications you are taking before starting tocilizumab.

Frequently Asked Questions

Tocilizumab is primarily used to treat rheumatoid arthritis and other inflammatory conditions when other treatments have not been effective.

This medication is typically given as a subcutaneous injection by a healthcare professional or trained caregiver.

Availability may vary by region; consult a licensed pharmacy or healthcare provider for prescription requirements.

Common effects may include injection site reactions, headache, or upper respiratory infections.

Safety during pregnancy has not been established; consult a healthcare provider for personalized advice.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.